BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2655863)

  • 1. Expression of GCDFP-15 in breast carcinomas. Relationship to pathologic and clinical factors.
    Mazoujian G; Bodian C; Haagensen DE; Haagensen CD
    Cancer; 1989 Jun; 63(11):2156-61. PubMed ID: 2655863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin.
    Wick MR; Lillemoe TJ; Copland GT; Swanson PE; Manivel JC; Kiang DT
    Hum Pathol; 1989 Mar; 20(3):281-7. PubMed ID: 2542151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features.
    Mazoujian G; Pinkus GS; Davis S; Haagensen DE
    Am J Pathol; 1983 Feb; 110(2):105-12. PubMed ID: 6130702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast gross cystic disease protein 15 in human breast cancer in culture.
    Miller WR; Shivas AA; Franchimont P; Haagensen DE
    Eur J Cancer Clin Oncol; 1988 Feb; 24(2):223-8. PubMed ID: 3356211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoperoxidase localization of GCDFP-15 with mouse monoclonal antibodies versus rabbit antiserum.
    Mazoujian G; Parish TH; Haagensen DE
    J Histochem Cytochem; 1988 Apr; 36(4):377-82. PubMed ID: 3279111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary signet ring cell carcinoma of the eyelid: report of a case demonstrating further analogy to lobular carcinoma of the breast with a literature review.
    Langel DJ; Yeatts RP; White WL
    Am J Dermatopathol; 2001 Oct; 23(5):444-9. PubMed ID: 11801778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of GCDFP-15 and GCDFP-24 in mammary and non-mammary tissue.
    Satoh F; Umemura S; Osamura RY
    Breast Cancer; 2000 Jan; 7(1):49-55. PubMed ID: 11029771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical analysis of pleomorphic lobular carcinoma: higher expression of p53 and chromogranin and lower expression of ER and PgR.
    Radhi JM
    Histopathology; 2000 Feb; 36(2):156-60. PubMed ID: 10672061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signet ring variant of lobular carcinoma of the breast: a clinicopathologic and immunohistochemical study.
    Raju U; Ma CK; Shaw A
    Mod Pathol; 1993 Sep; 6(5):516-20. PubMed ID: 8248106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemistry of GCDFP-24 and zinc alpha2 glycoprotein in benign sweat gland tumors.
    Mazoujian G
    Am J Dermatopathol; 1990 Oct; 12(5):452-7. PubMed ID: 2244662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apocrine differentiation in lobular carcinoma of the breast: a morphologic, immunologic, and ultrastructural study.
    Eusebi V; Betts C; Haagensen DE; Gugliotta P; Bussolati G; Azzopardi JG
    Hum Pathol; 1984 Feb; 15(2):134-40. PubMed ID: 6365733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PIP/GCDFP-15 gene expression and apocrine differentiation in carcinomas of the breast.
    Pagani A; Sapino A; Eusebi V; Bergnolo P; Bussolati G
    Virchows Arch; 1994; 425(5):459-65. PubMed ID: 7850069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast.
    Honma N; Takubo K; Akiyama F; Sawabe M; Arai T; Younes M; Kasumi F; Sakamoto G
    Histopathology; 2005 Aug; 47(2):195-201. PubMed ID: 16045781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E-cadherin immunohistochemical analysis of histiocytoid carcinoma of the breast.
    Gupta D; Croitoru CM; Ayala AG; Sahin AA; Middleton LP
    Ann Diagn Pathol; 2002 Jun; 6(3):141-7. PubMed ID: 12089723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women.
    Sapino A; Righi L; Cassoni P; Papotti M; Gugliotta P; Bussolati G
    Mod Pathol; 2001 Aug; 14(8):768-76. PubMed ID: 11504836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemistry of gross cystic disease fluid protein (GCDFP-15) in 65 benign sweat gland tumors of the skin.
    Mazoujian G; Margolis R
    Am J Dermatopathol; 1988 Feb; 10(1):28-35. PubMed ID: 2459984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of neuroendocrine carcinoma of the breast.
    Sapino A; Papotti M; Righi L; Cassoni P; Chiusa L; Bussolati G
    Ann Oncol; 2001; 12 Suppl 2():S115-7. PubMed ID: 11762336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kappa casein, lactalbumin and GCDFP 70 localization in human breast carcinomas: an immunohistochemical study using the avidin-biotin-peroxidase complex method.
    Charpin C; Martin PM; Lachard A; Jacquemier J; Lavaut MN; Andonian C; Pourreau-Schneider N; Toga M
    Med Oncol Tumor Pharmacother; 1985; 2(2):103-12. PubMed ID: 2997552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical study with antibody to glycoprotein GCDFP-15 for metastatic lung cancer from breast cancer.
    Nonami Y; Hisa S; Yamamoto A; Sasaguri S; Kiyoku H; Kurumaya H
    J Cardiovasc Surg (Torino); 2001 Aug; 42(4):561-4. PubMed ID: 11455297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleomorphic lobular carcinoma of the breast: clinicopathologic features of 12 cases.
    Bentz JS; Yassa N; Clayton F
    Mod Pathol; 1998 Sep; 11(9):814-22. PubMed ID: 9758360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.